News

Accuryn Medical Announces Leadership Transition

Rich Keenan and Sanjay Banerjee Named Co-CEOsHAYWARD, CA / ACCESSWIRE / April 17, 2024 / Accuryn Medical, innovator of the…

2 years ago

CharmHealth Unveils 2024 Innovation Challenge to Bring Creative Solutions to the Fingertips of Healthcare Providers

Call for Proposals Now Open to Digital Health Startups to Compete on the CharmHealth EcosystemPLEASANTON, Calif.--(BUSINESS WIRE)--#AI--CharmHealth, a leader in…

2 years ago

Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and Functional Inhibition

LUND, SE / ACCESSWIRE / April 17, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported publication of…

2 years ago

Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will…

2 years ago

Suki Assistant Receives 93.2 Overall Performance Score in 2024 KLAS Spotlight Report

Respondents indicate that the company’s ambient AI solution is highly effective in decreasing burnout, improving same-day closures, and driving tangible…

2 years ago

Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

Study will assess the clinical utility and workflow benefits of physicians using images acquired by the Swoop® Portable MR Imaging®…

2 years ago

Establishment Labs Announces Participation in The Aesthetic Meeting 2024

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

2 years ago

Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.

Agreement designed to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis SystemSAN JOSE, Calif.--(BUSINESS WIRE)--Outset…

2 years ago

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development,…

2 years ago

NervGen Pharma Reports 2023 Year-End Financial Results and Operational Updates

Anticipated completion of enrollment of the chronic cohort in the Phase 1b/2a clinical trial in Q2 2024CA$23 million bought deal…

2 years ago